TTechnology Read More Smartwatch data may help detect opioid misuse riskFebruary 6, 2026 Opioid overdoses continue to take a devastating toll across the United States. According to the U.S. Centers for…
MMedication Read More Millionaire GP who owns 14 hotels and a brewery administered fentanyl sedation in breach of AHPRA conditions: tribunalJanuary 29, 2026 Dr Jerry Schwartz says he will appeal after being found guilty of breaching conditions on his registration by…
MMental health Read More New mobile unit to help communities with mental health after Helene :: WRAL.comDecember 27, 2025 More than a year after Hurricane Helene devastated communities in western North Carolina, health providers say the emotional…
NNutrition Read More Arizona AG warns about synthetic supplements sold in convenience storesDecember 10, 2025 PHOENIX (AZFamily) — The state’s chief legal officer is warning Arizonans about what she calls “dangerous products” being…
MMedication Read More INVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain – MedShadow FoundationNovember 4, 2025 Fact Checked FACT CHECKED Pain was one of the first sensations Brandy, 44, remembers. Born with spina bifida…
HHealth Read More Global drug addiction mortality rates double despite fewer new casesOctober 15, 2025 Despite fewer new addiction cases worldwide, a sweeping analysis finds drug-related deaths surging, exposing critical failures in global…
MMedication Read More Popular opioid painkiller doesn’t ease chronic pain: new studyOctober 8, 2025 Talk about a dose of disappointment. A new analysis suggests that millions of Americans with chronic pain are…
HHealth Read More Innovative approaches target PAR2 receptor to alleviate gut painOctober 7, 2025 Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome. In…
MMedication Read More NY settlement highlights risks, costs of Indivior’s overdose drugSeptember 30, 2025 The pharmaceutical manufacturer Indivior has stopped marketing Opvee, its controversial overdose-reversal medication, after two years of meager sales,…